1. OS4.1 MEVITEM: A European, randomized, open-label, Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or refractory medulloblastoma presenting an activation of the Sonic Hedgehog (SHH) pathway. (6th September 2019) Authors: Frappaz, D; Barritault, M; Montané, L; Laigle-Donadey, F; Chinot, O; Le Rhun, E; Bonneville-Levard, A; Meyronnet, D; Garin, G; Pérol, D Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P14.04 10 years of weekly web conference for brain tumor of Adolescent/Young Adult (AYA) on behalf of ANOCEF, GO-AJA and SFCE societies. (6th September 2019) Authors: Frappaz, D; Bronnimann, C; Faure Conter, C; Vauleon, E; Meyronnet, D; Sunyach, M; Leblond, P; Tanguy, R; Laurence, V; Bonneville-Levard, A Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗